Soo-Youl Kim
Chief Executive Officer & Principal Scientist New Cancer Cure-Bio & National Cancer Center
Seminars
Wednesday 17th September 2025
Emerging Cancer Therapeutic Approach to Overcome Challenges of Targeted Therapeutics & Treat RAS-Driven Cancers
2:30 pm
- Uncovering a new technology to eliminate RAS and cancer driver genes by fatty acid oxidation (FAO) inhibition
- Overcoming overcome drug resistance and reversing high-fat diet induced tumor growth promotion by FAO inhibition
- Highlighting phase 1 results and movement into phase 2 clinical trial
